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Abstract
Zwitterionic capsular polysaccharides (ZPS) of commensal bacteria are characterized by having both positive and negative
charged substituents on each repeating unit of a highly repetitive structure that has an a-helix configuration. In this paper
we look at the immune response of CD8
+ T cells to ZPSs. Intraperitoneal application of the ZPS Sp1 from Streptococcus
pneumoniae serotype 1 induces CD8
+CD28
2 T cells in the spleen and peritoneal cavity of WT mice. However, chemically
modified Sp1 (mSp1) without the positive charge and resembling common negatively charged polysaccharides fails to
induce CD8
+CD28
2 T lymphocytes. The Sp1-induced CD8
+CD28
2 T lymphocytes are CD122
lowCTLA-4
+CD39
+. They
synthesize IL-10 and TGF-b. The Sp1-induced CD8
+CD28
2 T cells exhibit immunosuppressive properties on CD4
+ T cells in
vivo and in vitro. Experimental approaches to elucidate the mechanism of CD8
+ T cell activation by Sp1 demonstrate in a
dimeric MHC class I-Ig model that Sp1 induces CD8
+ T cell activation by enhancing crosslinking of TCR. The expansion of
CD8
+CD28
2 T cells is independent, of direct antigen-presenting cell/T cell contact and, to the specificity of the T cell
receptor (TCR). In CD8
+CD28
2 T cells, Sp1 enhances Zap-70 phosphorylation and increasingly involves NF-kB which
ultimately results in protection versus apoptosis and cell death and promotes survival and accumulation of the CD8
+CD28
2
population. This is the first description of a naturally occurring bacterial antigen that is able to induce suppressive
CD8
+CD28
2 T lymphocytes in vivo and in vitro. The underlying mechanism of CD8
+ T cell activation appears to rely on
enhanced TCR crosslinking. The data provides evidence that ZPS of commensal bacteria play an important role in peripheral
tolerance mechanisms and the maintenance of the homeostasis of the immune system.
Citation: Mertens J, Fabri M, Zingarelli A, Kubacki T, Meemboor S, et al. (2009) Streptococcus pneumoniae Serotype 1 Capsular Polysaccharide Induces CD8
+CD28
2
Regulatory T Lymphocytes by TCR Crosslinking. PLoS Pathog 5(9): e1000596. doi:10.1371/journal.ppat.1000596
Editor: Jeffrey N. Weiser, University of Pennsylvania, United States of America
Received May 19, 2009; Accepted August 28, 2009; Published September 25, 2009
Copyright:  2009 Mertens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Deutsche Forschungsgemeinschaft (KA 1398/2 to W.M.K.-M.), Maria-Pesch Foundation (to M. F., W.M.K.-M.), and Ko ¨ln
Fortune Program (to W.M.K.-M., JM, TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wkalkamoll@labor-stein.de
¤ Current address: MVZ Dr. Stein + Kollegen, Mo ¨nchengladbach, Germany
. These authors contributed equally to this work.
Introduction
Humans are colonized by multitudes of commensal organisms
the importance of which is now recognized for good health.
Capsular polysaccharides of the physiologic human bacterial flora
are immunogenic components that first encounter the immune
system during their initial colonization, and, at the time the
immune system is developing and maturing. As opposed to
common negative charged polysaccharides, the biologic activity of
polysaccharides from certain commensal bacteria is unique in their
ability to stimulate CD4
+ T cells in vivo and in vitro [1,2,3,4,5].
Examples of such bacteria are, Bacteroides fragilis the ubiquitous
anaerobic member of the gut flora, Staphylococcus aureus a
temporary member of the skin and mucosal flora, and, Streptococcus
pneumoniae of the upper respiratory tract flora. CD4
+ T cell
activation induced by these polysaccharides depends on their
unique electrical charge. Each repeating unit has a minimum of
one positive and one negative charge leading to their common
three-dimensional configuration characterized by a right-handed
helix with repeating negatively charged grooves, the positive
charges being on the outer surface of the lateral boundaries
[1,4,6,7]. Elimination of their charged groups abrogates T cell-
dependent immune responses in vitro and in vivo [1]. Introduction of
a zwitterionic charge motif into a non-ZPS converts a T cell-
independent polysaccharide into a CD4
+ T cell-dependent antigen
[1,8]. Presentation of the so-called zwitterionic polysaccharide
(ZPS) from S. pneumoniae serotype 1 (Sp1) by MHC class II
molecules requires its retrograde transport from lysosomes to the
cell surface within tubules as a ZPS/MHC class II complex and
also, the DM molecule [9,10]. Binding studies suggest that ZPS
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ZPS directs the development of the systemic cellular immune
response by correcting CD4
+ T cell deficiencies and TH1/TH2
imbalances towards a TH1 immune response [12]. Intraperitoneal
application of ZPS, such as PS A1 from B. fragilis or Sp1 from S.
pneumoniae, with adjuvant, promotes CD4
+ T cell-dependent intra-
abdominal abscess pathology [5,13], whereas subcutaneous ZPS
application without adjuvant induces regulatory IL-10-secreting
CD4
+ T cells that protect from abscess formation [14]. Recently, it
was shown that oral application of ZPS prevents inflammatory
bowel disease (IBD) [15]. The ZPS PS A1 protects from IBD
through a functional requirement for interleukin (IL)-10-produc-
ing CD4
+ T cells.
A significant number of potentially self-reactive lymphocytes
leave the primary lymphoid organs and are kept under control by
‘‘peripheral tolerance mechanisms’’ [16]. Probably the most
important of these mechanisms is assured by regulatory CD4
+
and CD8
+ T lymphocytes capable of suppressing adaptive and also
innate immune-responses [17,18]. Regulatory T cells are known to
control immune responses to self-antigens but also to nonself-
antigens (e. g. upon infection [19,20]) and to innocuous (probably
non-self) antigens in intestinal mucosa [21]. ‘‘Naturally’’ occurring
regulatory/suppressive CD8
+ T lymphocytes (Ts) constitute an
endogenous long-lived population of T cells that develop in the
thymus [22,23]. In mice, CD8
+CD122
+ T cells have received
special attention. As naturally occurring Ts, they are regarded as a
functional T cell subset that affects immunity through the release
of the anti-inflammatory cytokine IL-10 [24,25]. They are
believed to have specificity for self antigens and are poised to
prevent autoimmunity [26]. Mice genetically deficient for CD122
(the IL-2/IL-15 b-receptor chain), spontaneously develop severe
hyperimmunity. Furthermore, adoptive transfer of CD8
+CD122
+
Ts ameliorates established experimental autoimmune encephalo-
myelitis [27]. Another population of described Ts is termed
‘‘adaptive’’ or ‘‘induced’’ because these Ts are induced after one
time or several rounds of stimulation with cytokines, antibodies,
allogeneic or xenogeneic stimulator cells, antigen-pulsed APCs, or
antigens mostly of an artificial synthetic peptide (overview in [28]).
However, data from in vitro induced CD8
+CD28
2 Ts after
priming with specific antigens suggests that the Ts do not respond
to the priming antigens [29]. No natural antigen either self, or
tumor, or bacterial, has ever been demonstrated to induce the
differentiation of CD8
+CD28
2 T cells or any other subset of
CD8
+ Ts in vitro or in vivo.C D 8
+CD28
2 Ts were shown to
suppress autologous and heterologous CD4
+ T cell proliferation
by rendering APC tolerogenic through the induction of receptors
that transmit negative signals. Specifically, upregulation of
immunoglobulin-like transcripts (ILT) 3 and ILT4 [30].
CD8
+CD28
2 Ts have been attributed to be players in
autoimmunity [31]. IL-10 producing CD8
+CD28
2 Ts infiltrate
tumors, circulate in the peripheral blood of the majority of cancer
patients, and inhibit both proliferative and cytotoxic T cell
responses in this setting [32]. Moreover, CD8
+CD28
2 Ts seem to
regulate immune-responses in inflammatory disease [33].
CD8
+CD28
2 Ts are also involved in the control of mucosal
immune responses. In an IBD model [34], in contrast to
CD8
+CD28
+,C D 8
+CD28
2 T cells freshly isolated from the
spleen or gut of naı ¨ve mice, being rather ‘‘natural’’ Ts, effectively
prevent the development of colitis. CD8
+CD28
2 T cells derived
from IL-10–deficient mice lack the functional ability to prevent
colitis. Moreover, IBD induced with colitogenic T cells incapable
of responding to TGF-b is not prevented with CD8
+CD28
2 Ts.
These data suggest that in addition to IL-10, TGF-b also seems to
play a role in the suppressive activity of CD8
+CD28
2 Ts. Other
‘‘naturally’’ and ‘‘adaptive’’ murine and human Ts populations
have also been described [35,36,37,38,39,40]. Various cell
surface markers such as, CTLA-4, CD25, CD62L, CD122 and
the lack of expression of CD28, CD44, the synthesis of the
cytokines TGF-b and IL-10, and the expression of Foxp3 have
been reported in Ts [28]. Not all cell surface markers are
expressed on one subset of Ts, and not all cytokines are produced
by one particular Ts subset. It is currently unknown whether the
different types of Ts are distinct cell populations, overlapping, or,
are essentially derived from one source. They seem to emerge
after T cell receptor (TCR) stimulation, and exhibit their down-
regulatory function by impairing the responsiveness of other
T cells.
TCR is the primary trigger for antigen-mediated T cell
stimulation. In principal three different mechanisms of antigen
recognition by the TCR are known [41]. Firstly, conventional
peptide antigens are loaded onto MHC molecules within the
binding groove for antigen recognition by the TCR. Secondly,
superantigens polyclonally activate T cells by bridging the outer
surface of the MHC and the TCR molecule. Thirdly, mitogens
and lectins induce T cell activation by crosslinking T cell surface
molecules such as the TCR and CD3.
For all three mechanisms, engagement of the TCR by an antigen
translates into an intracellular signal by inducing a phosphorylation
cascade resulting in the activation of f-associated protein of 70 kDa
(Zap-70). Activated Zap-70 phosphorylates scaffold proteins
resulting in the activation of transcription factors such as NFkB
that initiate gene programs promoting proliferation, differentiation,
and effector actions of T cells. TCR- and co-stimulatory CD28-
mediated signaling effect the susceptibility to apoptosis.
Previous investigations have exclusively focused on the role of
effector and regulatory CD4
+ T cells in ZPS-mediated immune
responses. However, the role of CD8
+ T cells in ZPS-mediated
immunity has not been addressed to date. Here, we analyzed the
ability of a ZPS to regulate CD4
+ T cell immune responses
through CD8
+ T cells. We found that Sp1 induces the expansion
of regulatory CD8
+CD28
2 T lymphocytes in vitro and in vivo and
we assessed their function and activation mechanism.
Author Summary
One of the most difficult challenges for the mammalian
immune system is to protect its host from pathogens and
cancer while at the same time avoiding a self-destructive
or overwhelming immune response. In addition to so-
called central tolerance induced in the thymus, the
immune system relies on peripheral control mechanisms.
One of the most important brakes of the peripheral
tolerance system is constituted by so-called regulatory T
lymphocytes. The predominately investigated regulatory T
lymphocytes belong to the CD4
+ subset but CD8
+
regulatory T lymphocytes are now also believed to play a
major role in controlling immune responses. Herein, we
describe for the first time a natural occurring saccharide
antigen from a commensal bacterium which induces the
accumulation of a defined population of CD8
+ regulatory T
lymphocytes. These CD8
+ regulatory lymphocytes sup-
press inflammatory immune responses in vivo and in in
vitro assays. We also describe how the bacterial antigen
induces the activation of CD8
+ T cells. Our findings not
only describe a novel mechanism of saccharide-mediated T
cell activation but also provide evidence that commensal
bacteria play an important role in the induction of
peripheral tolerance and maintenance of the mammalian
immune system.
CD8
+CD28
2 Induction by Zwitterionic Polysaccharide
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CD8
+CD28
2 T cells modulate Sp1-mediated CD4
+ T cell-
dependent intraperitoneal abscess formation
To study CD8
+ T cell immunity to ZPS, we first employed a
well characterized experimental model of CD4
+ T cell-dependent
immune response, which is the mouse model of Sp1-mediated
abscess formation [10]. Whole ZPS-positive commensal bacteria
or their ZPS, such as Sp1, induce intraperitoneal abscesses when
applied intraperitoneally with sterile cecal content (SCC)
adjuvant [1]. Application of adjuvant alone and chemically
modified Sp1 (mSp1) plus adjuvant, as negative controls, do not
induce abscesses (Fig. 1A). In contrast, challenging C57BL/6 WT
mice with intraperitoneal Sp1 plus adjuvant results in the
formation of sterile abscesses six days later. The median abscess
size of Sp1-challenged mice is 2 mm (one abscess/mouse). CD4
+
T cell-dependency of this immune response is confirmed, as
CD4
+ T cell depletion leads to significant inhibition of abscess
formation (no abscesses observed). In contrast, CD8
+ Tc e l l
depletion results in the formation of significantly larger abscesses
with a median abscess size of 7 mm (one abscess/mouse).
Immunohistochemical analysis of Sp1-mediated intraperitoneal
abscesses shows that CD8
+ T cells participate in the formation of
the organized wall of abscesses (Fig. 1B). Intraperitoneal Sp1
challenge results in a significant increase of the total cell count in
the peritoneal cavity peaking at 24 h and 36 h following Sp1
challenge [42]. The cellular influx mainly consists of neutrophils
and macrophages (not shown). DCs (about 7%) and CD4
+ T cells
(about 1%) also are attracted by Sp1 into the peritoneal cavity
[10,42]. Here, we analyzed the quantity and phenotype of CD8
+
T cells migrating into the peritoneum after Sp1 application. To
establish the distinction of CD28
2 and CD28
+ CD8
+ T cells
fluorescent staining of CD28 was performed with native spleen
CD8
+ T cells that contained a mixture of CD28
2 and CD28
+
CD8
+ T cells (data not shown). As no clear CD8
+CD28
2
population could be distinguished CD8
+CD28
2 cells are
therefore defined as those expressing CD28 at background
isotype levels. The thus defined CD28
2 population represents
about 30% of CD8
+ splenocytes as previously described [34].
Flow cytometry analysis of the CD28 phenotype of CD8
+ Tc e l l s
migrating into the peritoneal cavity 24 h and 36 h after Sp1
challenge reveals that almost all CD8
+ T cells are CD8
+CD28
2
cells (Fig. 1C). We conclude that Sp1 attracts CD8
+C28
2 Tc e l l s
into the peritoneal cavity that modulate CD4
+ T cell-dependent
abscess formation.
Sp1 induces CD8
+CD28
2 T lymphocytes positive for TGF-
b and IL-10
To further characterize the phenotype of the Sp1-induced
CD8
+CD28
2 T lymphocytes, we first investigated whether
intraperitoneal Sp1-challenge also induces CD8
+CD28
2 T cells
in the spleens of C57BL/6WT mice which had been challenged
the day before with intraperitoneal Sp1. Compared to SCCA-
and mSp1-challenged mice, Sp1 induces an expansion of
CD8
+CD28
2 T cells by 27% and 24%, respectively (Fig. 2A).
Different CD8
+CD28
2 T cell subpopulations have been
characterized by means of the appearance of the surface markers
expressed and secretion of cytokines. Sp1-induced CD8
+ T cells
expressed CD122, albeit mainly at low levels (Fig. 2B). Whereas
all CD8
+CD28
2 cells were CD122
low, a fraction of CD8
+CD28
+
cells expressed high levels of CD122. To analyze the expression
of markers that allow the distinction of naı ¨ve, activated, and
memory T cells, we stained the Sp1-induced CD8
+CD28
2
T cells and CD8
+CD28
+ T cells as controls with CD44, CD25,
and CD62L (Fig. 2B). Amongst CD28
+ cells, a population of
CD44
high activated/memory CD8
+ T cells was found. In
contrast, CD28
2 cells homogenously expressed CD44 at a low
level (50% positive cells) that implies a naı ¨ve phenotype. Further
phenotyping by determination of the CD25 and CD62L surface
markers of Sp1-induced CD8
+CD28
2 T cells showed a CD25
low
and CD62L
high pattern which confirms them as naı ¨ve quiescent
CD8
+ T cells [34,43,44,45]. We also determined the expression
of CTLA-4 and CD39. CD39 is an ectonucleotidase that had
been found positive in CD4
+ regulatory T cells [46].
CD8
+CD28
2 T cells show an increased expression of CTLA-4
(22%) and CD39 (19%) when compared to CD8
+CD28
+ T
lymphocytes.
Immunomodulation by several regulatory T cell populations
often involves TGF-b and IL-10. We therefore investigated if
CD8
+CD28
2 cells can produce these cytokines. CD8
+CD28
2 T
cells were isolated from spleens of mice challenged the day before
with Sp1, and mSp1, or SCC alone as controls. Latency
Associated Peptide (LAP) is a proteolytic product of the pro
TGF-b1 protein and its surface expression is therefore limited to
TGF-b1 expressing cells [47]. As shown in Fig. 2C, in comparison
to mice challenged with SCC and mSp1 plus SCC, a substantial
proportion (34%) of CD8
+CD28
2 cells expressed LAP. We
observed that a substantial proportion (21%) of CD8
+CD28
2
cells produced IL-10. All groups showed background levels which
is likely due to basic cytokine expression caused by the adjuvant
SCC. However, the detection of IL-6, that has not been described
to play a role in immunosuppressive CD8
+ T cell and thus was
used as a negative control, was low at 5%.
Sp1-induced CD8
+CD28
2 T cells suppress CD4
+ T cell-
dependent immune responses
To address the function of Sp1-induced CD8
+CD28
2 T cells,
we investigated their effect on CD4
+ T cell responses. First, we
examined the effect of CD8
+CD28
2 T cells on ZPS-induced
abscess formation. In contrast to the adoptive transfer of Sp1-
induced CD8
+CD28
+ T cells that together cause intraperitoneal
abscesses with a median abscess size of 4 mm, transfer of Sp1-
induced CD8
+CD28
2 T lymphocytes significantly inhibited the
abscess formation (no abscess detected) (Fig. 3A). The intraperi-
toneal application of Sp1, as a positive control, induced abscesses
with a median abscess size of 4 mm (one abscess/mouse), and the
application of SCC alone and SCC plus mSp1 as negative
controls, did not induce abscess formation. Transfer of
CD8
+CD28
2 T lymphocytes from naı ¨ve mice also suppressed
abscess formation (data not shown).
We also addressed the functional role of Sp1-induced
CD8
+CD28
2 T lymphocytes in a mixed leukocyte reaction.
DCs and CD4
+ T cells of different haplotypes were co-incubated
to provoke a mixed leukocyte reaction (MLR). Proliferation of the
CD4
+ T lymphocytes was visualized by their CFSE staining and
flow cytometry. Fig. 3B demonstrates that in the absence of CD8
+
T cells a proliferative response of CD4
+ T lymphocytes takes
place. When CD8
+CD28
+ T cells are added, CD4
+ T lymphocytes
proliferate to a similar degree. However, the co-incubation of DCs
and CD4
+ T cells in the presence of CD8
+CD28
2 T lymphocytes
results in an efficient reduction of CD4
+ T cell proliferation that is
comparable to the control with non-proliferating CFSE-labeled
CD4
+ T cells measured on day 0 of incubation. These
investigations show that Sp1-induced CD8
+CD28
2 T lympho-
cytes efficiently suppress a Sp1-mediated CD4
+ T cell-dependent
immune response in vivo and a strong non-antigen-specific CD4
+ T
cell response in vitro.
CD8
+CD28
2 Induction by Zwitterionic Polysaccharide
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+ T cells modulate abscess formation in response to intraperitoneal Sp1-application. A. C57BL/6 WT mice received an anti-
CD4-mAb, an anti-CD8-mAb, or PBS intravenously 24 h prior to intraperitoneal Sp1-challenge, or challenge with chemically modified Sp1 (mSp1) plus
sterile cecal content (SCC) adjuvant, or SCC alone as controls. After 6 days, examination for intraperitoneal abscess formation was performed at
autopsy. Each dot represents the abscess diameter per mouse; bars indicate the median abscess size per group; *p,0.05. The experiment was
performed three times independently with 6 mice per group, respectively. One representative experiment is shown in the figure.
B. Immunohistochemistry of Sp1-induced abscesses was performed with an anti-CD8-mAb. The left panel shows an overview of an abscess. The
right panel shows the magnified detail of the abscess wall within the rectangular box of the left panel. Some CD8
+ T cells are labeled with black
arrows. The figures show one representative result out of three experiments. C. The influx of CD8
+ and CD8
+CD28
2 T cells into the peritoneum was
determined in C57BL/6 mice challenged with Sp1 or mSp1 plus SCC as a control. The peritoneal lavage was performed at different time intervals
(x-axis) after challenge. Cell numbers were determined by cell counting and flow cytometry. Bars indicate standard deviations within a tested group;
*p,0.05. The experiment was performed two times with each 4 mice per group and time point. The figure shows one representative result.
doi:10.1371/journal.ppat.1000596.g001
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+CD28
2 T lymphocytes is independent
of direct APC/T cell contact and cytokines secreted by
APCs
To address the mechanism of the induction of CD8
+CD28
2 T
cells by the Sp1 antigen, we first investigated the induction of
CD8
+CD28
2 T lymphocytes by Sp1 in vitro. We stimulated spleen
cells of C57BL/6 WT mice with Sp1, and mSp1 or medium alone
as controls in vitro, and quantified the CD8
+CD28
2 population by
flow cytometry. In comparison to medium- and mSp1-treated
spleen cells of which 34% or 33% are of the CD8
+CD28
2
phenotype, respectively, 59% of spleen cells stimulated with Sp1 are
characterized as CD8
+CD28
2 T cells (Fig. 4A). To investigate
whether direct contact between APC and CD8
+ T cells is required
for the induction of CD8
+CD28
2 T cells, purified CD8
+ T cells
separated from spleen cells via a membrane with a pore sizethat did
not allow APC/T cell contact, were treated with Sp1, mSp1, and
medium. In contrast to medium- or mSp1-treated cells, Sp1
treatment induced an increase of the CD8
+CD28
2 T cell
population in 21% and 23% respectively. This result left open the
question, do cytokines secreted by the APCs induce CD8
+CD28
2
Ts? We therefore performed an assay with purified CD8
+ T cells.
34% and 35% of CD8
+ T lymphocytes stimulated with medium
Figure 2. Phenotype of Sp1-induced CD8
+CD28
2 T lymphocytes in vivo. C57BL/6 WT mice were challenged intraperitoneally with Sp1, mSp1
(100 mg/mouse, respectively), or SCCA alone. After 18 h, spleen cells were isolated. Cells were stained for CD8 and CD28 surface expression and
prepared for flow cytometry. Flow cytometry histograms in A–C are representative for one out of five experiments with 4 mice each.
A. Intraperitoneal Sp1 application induces CD8
+CD28
2 T lymphocytes in vivo. The percentages 6SD (n=4) of the respective CD8
+CD28
2 cells are
given above the marker. B. For determination of the phenotype of the Sp1-induced CD8
+CD28
2 T lymphocytes in C57BL/6 mice, CD8
+CD28
2 and
CD8
+CD28
+ T cells were stained with antibodies specific for surface markers and prepared for flow cytometry analysis. Percentages of positive
cells6SD (n=4) for the CD8
+CD28
2 and CD8
+CD28
+ T cell subsets are displayed above the marker. C. C57BL/6 WT mice were challenged
intraperitoneally with Sp1, mSp1 (100 mg/mouse, respectively), or SCC alone. After 18 h, spleen cells were isolated. CD8
+CD28
2 cells were analyzed
for LAP surface expression and intracellular cytokines by flow cytometry. Percentages of positive cells 6SD (n=4) are given below the marker.
doi:10.1371/journal.ppat.1000596.g002
CD8
+CD28
2 Induction by Zwitterionic Polysaccharide
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2, whereas 68% of the Sp1-
treated purified CD8
+ T cells are of the CD28
2 phenotype. This
result indicates that Sp1-mediated induction of CD8
+CD28
2 T
lymphocytes is independent of direct contact between CD8
+ T cells
with APCs. Finally, we demonstrate that the induction of
CD8
+CD28
2 T lymphocytes relies on expansion of this cell
population (Fig. 4B). CFSE-labeled CD8
+ T cells were incubated
with Sp1, mSp1 and medium as controls, overnight and analyzed
for theirproliferationcapacity.Fig. 4B demonstrates that incontrast
to 7% of CD8
+CD28
+ T cells, 28% of CD8
+CD28
2 T cells
undergo cell division more than three times in response to Sp1.
Sp1 induces the proliferation of CD8
+CD28
2 T cells via
TCR signaling
Proliferation of T cells involves the engagement of TCR by an
antigen. We investigated whether CD8
+CD28
2 T lymphocyte
activation by Sp1 involves the TCR signaling cascade, resulting in
T cell activation and proliferation. Following TCR engagement by
an antigen, Zap-70 is rapidly phosphorylated which in turn results
in enhanced Zap-70 kinase activity and downstream signaling
events ultimately leading to NF-kB activation. We therefore
incubated CD8
+, CD8
+CD28
2, and CD8
+CD28
+ T cells in the
presence of Sp1, mSp1 or medium alone and analyzed Zap-70
phosphorylation by western blotting. As shown in Fig. 5A, in
contrast to medium alone or incubation with mSp1, treatment
with Sp1 results in increased phosphorylation of Zap-70 in CD8
+
T cells. Analysis of the CD28
2 and CD28
+ subpopulations
revealed that CD8
+CD28
2 T lymphocytes are significantly more
activated by Sp1 than CD8
+CD28
+ T lymphocytes. We next
investigated NF-kB translocation activation. In correlation with
the Zap-70 phosphorylation, Sp1 leads to significant NF-kB
activation in CD8
+ and CD8
+CD28
2 T lymphocytes, but not in
CD8
+CD28
+ T cells (Fig. 5B). It is important to note that CD8
+ T
cells treated with mSp1 and PBS as controls were not activated.
Sp1 prevents apoptosis and cell death of CD8
+CD28
2 T
lymphocytes
One of the central features of TCR-induced NF-kB action is to
promote the expression of several anti-apoptotic proteins which
enable cells to survive and to proliferate. To examine whether
Sp1-induced T cell activation simultaneously prevents apoptosis,
we treated CD8
+ T cells with polysaccharide antigens in the
presence or absence of staurosporine, a potent initiator of
apoptosis [48]. We performed FACS analyses of CD8
+CD28
2
and CD8
+CD28
+ T lymphocytes and examined the extracellular
exposure of annexin V as an indicator for apoptosis, and the
uptake of the cell death marker propidium iodide (PI). Fig. 6A
demonstrates that CD8
+CD28
2 T lymphocytes stimulated with
Sp1 are protected from apoptosis and apoptosis-mediated cell
death induced by staurosporine. Within the CD8
+CD28
2 T cell
population stimulated with Sp1, only 5% of cells were apoptotic,
and 1% were double-positive for the apoptosis and cell death
marker - similar to the cells without staurosporine treatment. In
contrast, non- and mSp1-treated CD28
2 T cells are significantly
susceptible to staurosporine-mediated apoptosis and cell death.
27% and 28% of CD8
+CD28
2 T cells, respectively, stained
positive for annexin V and 8% and 9%, respectively, stained
double-positive for annexin V and PI. Strikingly, Sp1 treatment
does not confer any anti-apoptotic effect in the CD8
+CD28
+ T cell
population. In this population, the percentage of apoptotic cells
was similar to Sp1-, mSp1-, and non-treated cells (36%, 30%, and
32%, respectively). The same is true for the apoptosis and cell
death double-positive cells (12%, 8%, and 11%, respectively).
Figure 3. Sp1-induced CD8
+CD28
2 T lymphocytes suppress
CD4
+ T cell immune responses in vivo and in vitro.A .Sp1-induced
CD8
+CD28
2 T lymphocytes suppress intraperitoneal abscess formation.
C57BL/6 mice received intraperitoneal Sp1 challenge (100 mg), and
challenge with mSp1 (100 mg), or, SCC adjuvant alone as controls, in the
presence or absence of simultaneous intraperitoneal administration of
CD8
+CD28
2 or CD8
+CD28
+ T cells (4610
5 cells per mouse). Intraper-
itoneal abscess formation was examined at autopsy after 6 days. Each
dot represents the abscess diameter per mouse; bars indicate the
median abscess size per group; *p,0.05. B. Sp1-induced CD8
+CD28
2 T
cells suppress CD4
+ T cell proliferation in vitro. MLR was performed with
DCs from Balb/c mice and CFSE-labeled CD4
+ T cells from C57BL/6 mice
in the presence or absence of Sp1-induced CD8
+CD28
2 or CD8
+CD28
+ T
cells from C57BL/6 mice. Proliferation of CFSE-labeled CD4
+ T cells was
evaluated by flow cytometry. The upper histogram shows the result of
the incubation of DCs with CFSE-labeled CD4
+ T cells for 1 h (control),
the lower histograms show the results after 5 days of incubation. The
histograms show one representative experiment out of 3 assays
performed with cells from three mice each. The percentage of CFSE-
positive cells that exhibit proliferation between day 0 and day 5 is given
above the marker (6SD; n=3).
doi:10.1371/journal.ppat.1000596.g003
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examination of executioner caspase 3 activation in CD8
+CD28
2
T cells treated with staurosporine. In resting and non-apoptotic
cells caspase 3 is a p32 proenzyme which is proteolytically
processed in apoptotic cells and forms an active p19 mature
enzyme. The irreversible proteolytic processing of caspase 3 serves
as an indicator for ongoing apoptotic process. These analyses
underscore the anti-apoptotic potential of Sp1 and significantly
demonstrated that Sp1 treatment specifically inhibits staurospor-
ine-induced caspase 3 activity in CD8
+CD28
2 T cells but not in
CD8
+CD28
+ T cells (Fig. 6B). In summary, we show by these
analyses that Sp1 induces the activation and expansion of
CD8
+CD28
2 T cells via TCR engagement and down-stream
signaling which eventually results in inhibition of apoptosis in
CD8
+CD28
2 T cells.
Sp1 enhances TCR crosslinking
Activation of CD8
+CD28
2 T lymphocytes is mediated through
TCR signaling. To test whether the induction of the CD8
+CD28
2
T cell population depends on peptide specificity and TCR
specificity, we incubated spleen cells from OT-1 mice carrying a
transgenic TCR on their CD8
+ T cell surface for the specific
recognition of the ovalbumin sequence SIINFEKL with Sp1,
mSp1, or medium alone as controls, in the presence of the
SIINFEKL peptide (10
29 M). Fig. 7A demonstrates that irrespec-
tive of the TCR specificity, Sp1 induces an increase of the CD28
2
T cell population within the SIINFEKL-stimulated CD8
+ T
lymphocytes (84% versus 30% and 31% of medium- and mSp1-
treated cells, respectively). We further analyzed Ts induction of
CD8
+ T cells with an artificial APC system that lacks APCs but
contains MHC class I molecules loaded with SIINFEKL peptide.
Compared to the negative control, Sp1 induced an increased
expression in the CD28
2 phenotype in 24% of CD8
+ T cells. We
also tested whether the induction of the CD8
+CD28
2 T cells
requires MHC class I molecules at all and cultured purified CD8
+
OT-1 T cells in the presence of SIINFEKL in medium alone, and
in medium containing mSp1 or Sp1. Compared to the medium
and mSp1 control, Sp1-treated CD8
+ T cells show an
CD8
+CD28
2 T cell increase of 32% and 27%, respectively.
These results demonstrate an APC- and MHC class I-independent
Figure 4. Sp1 induces CD8
+CD28
2 T lymphocytes in vitro.A .Total spleen cells from C57BL/6 WT mice, purified CD8
+ T cells from WT mice
separated by a transwell from WT spleen cells to prevent direct contact, and purified CD8
+ T cells alone were treated for 16 h in vitro with Sp1
(100 mg/ml), mSp1 (100 mg/ml), or medium alone (left panel). Cells were stained for CD8 and CD28 surface expression and prepared for flow
cytometry. The figure shows one representative histogram out of three assays performed with cells from 5 animals each. Percentages 6 SD of the
respective CD8
+CD28
2 cells are given in the upper right corner. B. CFSE-labeled CD8
+ T cells were analyzed immediately after CFSE-labeling
(medium, day 0), or incubated with Sp1, mSp1 (100 mg/ml, respectively), and medium overnight (o/n) and then analyzed for their proliferation
capacity by flow cytometry. The figure shows one representative result out of three experiments performed independently with cells from 3 mice.
The numbers above the marker in the histogram provides the percentage 6SD of T cells undergoing division for more than three generations,
respectively.
doi:10.1371/journal.ppat.1000596.g004
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2 phenotype by Sp1 in peptide-specific
CD8
+ T cells. At the same time, they allowed us to study the effect
of Sp1 on the TCR membrane organisation using a MHC-Ig
dimer model. Quantification of the TCR membrane organisation
was achieved by fitting the binding data into a model of
equilibrium dimerization of homogeneous monovalent receptors
by divalent ligand [49] (Fig. 7B; upper right box). In this model,
the first monovalent binding binds with single site affinity [50]. If
there is another receptor nearby then the dimer may bind with
both ‘‘arms’’ creating an ‘‘apparent binding affinity,’’ i.e., the
avidity. Since the receptors are identical, increases in avidity can
be attributed to increases in local concentration of receptors. In
this model the single site dissociation constant, Kd, characterizes
the binding of one site on the MHC to one TCR and the
dimensionless cross-linking constant, KxRt, characterizes the
ability of the MHC/TCR complex to recruit another TCR. The
binding avidity, Kv, is approximately the ratio Kd/KxRt [51].
When there is minimal cross-linking potential, KxRt is close to 1
and Kd and Kv are similar. If the cross linking potential Kx is high,
there is an enhancement of binding due to dimerization, resulting
in a stronger measured avidity than the intrinsic single site affinity.
Analysis of the binding data indicated that the overall avidity, Kv,
of the dimeric MHC in the presence of Sp1 was ,2.5-fold higher
than in the absence of Sp1 (Fig. 7B). The increased avidity of
MHC-Ig binding is due to an increased cross-linking constant
(Kx=0.58 cells/# in the absence of Sp1 vs. Kx=1.25 cells in the
presence of Sp1), rather than an increased intrinsic dissociation
constant (Kd=1.7 nM vs. Kd=1.2 nM), or to changes in the total
amount of receptors (Rt=9.9 # mean channel fluorescence (MCF)
vs. Rt=11.9 # MCF). Thus, the enhanced avidity results from an
increase in the cross-linking potential in the presence of Sp1.
Discussion
In this paper we describe the first ever identification of a
bacterial antigen that regulates CD4
+ T cell immune responses
through CD8
+ T cells. A model ZPS antigen of commensal
bacteria Sp1 induces CD8
+CD28
2 T lymphocytes which exhibit a
suppressive function on CD4
+ T cells in intraperitoneal abscess
formation and in an allogeneic CD4
+ T cell proliferation assay.
In the experimental model of abscess induction, CD8
+CD28
2
Ts represent a small population with about 0.1% of cells migrating
into the peritoneal cavity upon Sp1 challenge. A portion of these
cells is finally incorporated into the abscess wall. Although there is
a small number of Ts cells participating in abscess formation, their
depletion results in a significant enlargement of the abscess size,
suggesting that they have an important role in their ability to
regulate CD4
+ T cell responses. We provide evidence that the
Figure 5. Sp1 induces TCR-mediated activation in CD8
+CD28
2 T lymphocytes. A. Sp1 induces phosphorylation of Zap-70 kinase and total
Zap-70 kinase in CD8
+CD28
2 T lymphocytes. CD8
+, CD8
+CD28
2, and CD8
+CD28
+ were incubated in the presence of Sp1, mSp1 (100 mg/ml,
respectively), or in medium alone for 4 h. Western blotting was performed with a phospho-Zap-70, Zap-70 kinase-, and a b-actin-specific antibody as
a control. A representative blot out of three experiments is shown. B. Sp1 induces NF-kB activity in CD8
+CD28
2 T lymphocytes. CD8
+, CD8
+CD28
2,
and CD8
+CD28
+ were incubated in the presence of Sp1, mSp1 (100 mg/ml, respectively), or in medium alone for 2 h. The nuclear extract of treated
cells from 4 mice was analyzed by ELISA for NF-kB activity. As a positive control, the nuclear extract from Jurkat cells and as a negative control
complete lysis buffer was used. The experiment was repeated three times in an independent manner. Columns indicate the mean NF-kB activity, bars
indicate the standard deviation. **p,0.001,*p=0.01.
doi:10.1371/journal.ppat.1000596.g005
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+CD28
2 T cells indeed act as suppressor cells. A
regulatory/suppressive function of CD8
+CD28
2 Ts has been
demonstrated in various in vivo experimental models such as,
experimental autoimmune encephalitis and inflammatory bowel
disease [34,52]. However, this is the first ever demonstration that
they can efficiently prevent intra-abdominal abscess formation.
Abscess formation associated with secondary peritonitis, which is
the most frequent type of peritonitis, causes severe morbidity and
is often fatal with a mortality rate up to 30% [53,54]. Even with
optimal therapy including the administration of antibiotics and
surgical treatment, residual abscesses form in many patients
resulting in substantial morbidity and mortality [55]. Combining
the cited reports and the result presented here, strongly suggest
that CD8
+CD28
2 Ts cells play an important role in the
physiological control of not only intestinal and cerebral, but also,
of peritoneal immune responses.
Intraperitoneal application of Sp1 not only leads to an influx of
CD8
+CD28
2 T cells into the peritoneum but also to an increase of
these cells in the spleen, demonstrating a systemic effect of Sp1 on
the immune system. In contrast, mSp1 without the positive
charged substituent and therefore resembling a common nega-
tively charged polysaccharide not only fails to induce CD4
+ T cell-
dependent abscesses but also CD8
+CD28
2 T cells in the
peritoneum and in the spleen. Phenotype analysis of the Sp1-
induced CD8
+ T cells distinguishes them from the previously
reported ‘‘naturally’’ inhibitory CD8
+CD122
+ T cell population
[24,25]. The CD8
+CD28
2 T lymphocytes induced by Sp1 express
CD122 at a low level whereas the CD8
+CD122
+ population
described in these reports correspond to CD8
+CD122
high cells.
Furthermore, it appears that the CD28
+CD122
high identified in
our study are CD44
highCD62L
high thus classifying them as central
memory cells [56]. The Sp1-induced CD8
+CD28
2 Ts cells are
phenotype CD44
lowCD25
lowCD62L
high which categorizes them as
naı ¨ve T cells, thereby, again clearly distinguishing them from
CD8
+CD122
+ T cells. In conclusion, the induction of
CD8
+CD28
2 T lymphocytes by Sp1 reflects an expansion of
‘‘naturally’’ CD8
+CD28
2 naı ¨ve T cells that had been isolated in
spleens from naive C57BL/6 mice [34].
It is currently not understood whether the different types of
regulatory CD8
+ T cells described are distinct or overlapping cell
Figure 6. Sp1 prevents CD8
+CD28
2 T lymphocytes from apoptosis. A. CD8
+ T cells from C57BL/6 spleens were treated in medium in the
absence or presence of staurosporine with Sp1, mSp1 (100 mg/ml, respectively), or without antigen for 12 h. Magnetically separated CD8
+CD28
2 and
CD8
+CD28
+ cells were stained with FITC-conjugated Annexin V and 5 ml propidium iodide (PI), and prepared for flow cytometry. One representative
result out of three stainings with cells from 3 mice, respectively, is displayed. The numbers in the quadrants of the dot plots represent the percentage
6SD (n=3) of cells stained positive for the respective markers. B. Sp1 inhibits staurosporine-induced caspase 3 activity in CD8
+CD28
2 T cells. CD8
+,
CD8
+CD28
2, and CD8
+CD28
+ T cells were treated for 4 h with mSp1, mSp1 (100 mg/ml, respectively), or in medium alone. SDS-PAGE of the whole cell
extract was performed. One representative out of four western blots performed with a caspase 3- and a b-actin-specific antibody as a control is
shown.
doi:10.1371/journal.ppat.1000596.g006
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their characterization [28]. Given the need for a more coherent
and broader phenotyping we expanded the description of the Sp1-
induced CD8
+CD28
2 T cells to the surface markers CTLA-4 and
CD39. In contrast to the CD8
+CD28
+ T lymphocytes,
CD8
+CD28
2 T cells are CTLA-4
high. CTLA-4 interacts with
CD80 and CD86 expressed by APCs and by effector T cells to
suppress T cell activation [57,58]. CD4
+CD25
+ regulatory T cells
inhibit T cell activation of effector cells in vitro. Interaction of
CTLA-4 with CD80/CD86 is the only mechanism known to be
involved in this regulatory process [59]. It is important to further
study how and at what stage the CTLA-4 suppressor function
intervenes in regulating immunity.
In the immune system, extracellular ATP exhibits multiple pro-
inflammatory effects that can be inactivated by the ectoenzyme
CD39 (nucleoside triphosphate diphosphohydrolase-1). The cata-
lytic activity of CD39 is strongly enhanced by T cell receptor
ligation [59,60]. It was recently shown that CD39 is expressed
primarily by immunosuppressive regulatory CD4
+ T cells and that
CD39, together with CD73, efficiently distinguishes T regulatory
cells from other resting or activated T cells in mice [46,59,60].
Here, we observe a CD39
high phenotype on Sp1-induced
CD8
+CD28
2 Ts. This result suggests that CD39 may not only
be a marker on regulatory CD4
+ but also on CD8
+ Ts.
It has been suggested that IL-10 protects against inflammation
in numerous in vivo and in vitro systems [61,62]. A distinct
Figure 7. Sp1 induces peptide-specific CD8
+CD28
2 T lymphocytes and enhances TCR cross-linking on CD8
+ T cells. A. Sp1 induces
peptide-specific CD8
+CD28
2 T lymphocytes. Total spleen cells from OT-1 mice and purified OT-1 CD8
+ T cells alone (purity .95%) were treated with
SIINFEKL (10
29 M). SIINFEKL-loaded MHC class I dimers were coincubated with purified OT-1 CD8
+ T cells. Cells were treated for 16 h in vitro with Sp1
(100 mg/ml), mSp1 (100 mg/ml), or medium alone. Cells were stained for CD8 and CD28 surface expression and prepared for flow cytometry. The
percentages (6SD; n=4) of the respective CD8
+CD28
2 cells are given in one representative histogram out of three experiments performed
independently. B. Sp1 enhances TCR cross-linking on CD8
+ T cells. CD8
+ T cells from P14 mice were incubated with FITC-labeled and GP
33–41- or ASN-
loaded (nonspecific control) Db-Ig dimers in different concentrations in the presence or absence of Sp1. The mean fluorescence intensity was
measured by flow cytometry. Using ASN as a control for nonspecific binding, the specific binding of GP
33–41 (open circle) and GP
33–41 plus Sp1 (filled
circles) was calculated as described. A scatchard plot of the specific binding data is shown. The model fit parameters are summarized in the upper
right box. Kd is the single site equilibrium dissociation constant. Kx is the equilibrium cross-linking constant with units of inverse number for receptors
per cell. Rt is the total number of receptors available for binding in mean channel fluorescence (MCF) unit equivalents. Kv is the avidity at low dimer
concentrations, which is estimated as Kv,Kd/KxRt.
doi:10.1371/journal.ppat.1000596.g007
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+CD25
2 T cells produces IL-10 in response to
the ZPS Sp1 and is responsible for protection in an experimental
model of surgical fibrosis [14]. Here, we observe that ex
CD8
+CD28
2 T lymphocytes stimulated in vivo with Sp1 also
synthesize IL-10. We conclude that Sp1-induced CD8
+CD28
2 Ts
belong to the group of naturally occurring CD8
+ Ts that exhibit
their regulatory function through IL-10 [24,25,26,34,39,63,64,65].
TGF-b blocks T cell proliferation, Th1, and Th2 differentiation
[47]. Our data show that the Sp1-induced Ts express TGF-b1 (as
assessed by analysis of cell surface LAP). TGF-b has been
described to be secreted by various Ts subpopulations: a) naturally
occurring CD8
+CD28
2 Ts that prevented colitis in an experi-
mental IBD model, b) induced CD8
+ T cells that were generated
by myelin basic protein and protected animals from EAE, c)
CD8
+CD25
+Foxp3
+ that inhibited proliferation of responder T
cells in vitro, and d) CD8
+Foxp3
+ that prevented lupus
[34,66,67,68,69,70,71,72]. Most of these TGF-b-secreting Ts also
suppressed T and B cell responses in vitro. Sp1-induced
CD8
+CD28
2 Ts-derived IL-10 and TGF-b may not only
contribute in controlling peritoneal immunity but additionally,
modulate other inflammatory immune responses. It will be
important to evaluate the precise mechanisms involved in the
IL-10- and TGF-b-dependent prevention of intraperitoneal
abscess formation, and other inflammatory processes of the host
by Sp1-induced CD8
+CD28
2 regulatory T cells, because,
regulatory lymphocytes are an attractive target for the treatment
of various inflammatory processes.
The ZPS PS A2 from B. fragilis and Sp1 from S. pneumoniae are
known to form a wide right-handed a-helix structure with the
positively charged groups turned towards the outside of the
molecule allowing facultative interactions with protein molecules
or glycoproteins [6,7]. MHC class II molecules have open-ended
antigen binding grooves [41] and therefore can accommodate
antigen molecules that are larger than the groove, such as, the
15 kDa-size PS A1 or Sp1 saccharide. MHC class I has a closed
antigen binding groove and therefore it is unlikely that a ZPS
fragmentispresentedbyMHCclassI.Wetestedthishypothesisand
demonstrated that the expansionofCD8
+CD28
2Tsis independent
of direct contact of APC and T cell, and the MHC class I molecule.
Consequently, activation of CD8
+CD28
2 T cells due to presenta-
tion of Sp1 in the MHC class I binding groove or cross linkage of
MHC and TCR - similar to the activation mechanism employed by
superantigens – is excluded. Furthermore, APC-mediated NF-kB
activation of T cells through TCR has been shown to be dependent
on the engagement of CD28 co-receptor by its ligands B7-1 (CD80)
and B7-2 (CD86) on APCs [73]. However, Sp1 is capable to initiate
NF-kB activation in CD8
+ T cells lacking CD28 co-receptor.
Therefore, it is conceivable that Sp1 because of its pronounced
repetitive and charged structure binds externally to T cell surface
molecules such as the TCR that mediate an activation signaling
cascade. We demonstrate that Sp1 predominantly induces Zap-70
phosphorylation of the CD8
+CD28
2 subpopulation and ultimately
leads to their NF-kB activation. Consequently, this cell population is
protected from cell death. Several factors countering cell death
cascades have been shown to be positively regulated by NF-kB
activation. Inhibition of mitochondrial apoptotic cascade in
CD4
+CD28
2 T cells isolated from patients with rheumatoid
arthritis has been shown to be the underlying molecular mechanism
which gives rise to expansion and accumulation of CD4
+CD28
2 T
cells in these patients [74]. Here in CD8
+CD28
2 T cells, Sp1
confers resistance to the broad range kinase inhibitor staurosporine
which preferentially initiates mitochondrial apoptotic cascade [48].
Thus, Sp1 treatment promotes NF-kB activation in CD8
+CD28
2 T
cells which leads to blockade of mitochondrial apoptotic function.
However, the nature of this specific modification of mitochondrial
apoptotic machinery in CD8
+CD28
2 T cells by Sp1-treatment
remains to be determined.
The proliferation of Ts does not depend on the specificity of its
TCR which enabled us to approach investigations of the
mechanism of TCR activation. Dimeric MHC-Ig complexes have
been used as potential tools for studying T cell membrane
organizations [50,75]. By means of Db-Ig MHC-Ig dimers we
calculated the affinity, avidity, and the numbers of receptors on
GP
33–41-specific T cells, in the presence and absence of Sp1 during
antigen-specific binding. Since we did not see any relevant changes
regarding the affinity or numbers of the receptors, but a significant
increase in the avidity, we conclude that Sp1 exerts its T cell
activation via an enhanced cross-linking of TCRs. Data from in
vitro induced CD8
+CD28
2 T cells after priming with specific
antigens showed that the CD8
+CD28
2 Ts did not respond to the
priming antigens [29]. Our data indicate that Sp1 modulates
CD8
+ T cell responses induced by different specific peptides
through non-peptide- and non-TCR-specific enhancement of the
TCR cross-linking. T cell responsiveness to an epitope is affected
both by its affinity for the presenting MHC molecule as well as by
the affinity between the MHC-peptide complex and the TCR.
Low affinity interactions may result in weak T cell responses [76].
In this respect, ZPSs may enhance the stability and crosslinking of
the SMAC and subsequently trigger CD8
+ T cell immune
functions, including suppressive properties of CD8
+CD28
2 T
cells. On the other hand, since avidity changes in the TCR
represent a method of increasing the sensitivity of activated T cells
it is also possible that ZPS-mediated cross-linking of the TCR
sensitizes antigen-specific CD8
+ cells, including CD8
+CD28
2
suppressor cells, to lower levels of antigen [50]. We propose the
following model regarding the mechanism of Ts induction by ZPS:
ZPS crosslinks TCR molecules on CD8
+CD28
2 T lymphocytes
that are engaged in recognizing and binding to specific antigens of
foreign or self origin, and, lead to their activation, proliferation,
cytokine secretion and non-antigen-specific suppressive function
on T cells. Interestingly, proliferation of Ts does not depend on the
specificity of its TCR but clearly depends on the presence of the
positive charge on the polysaccharide molecule. This observation
implies that the zwitterionic charge that determines the three-
dimensional a-helix configuration is the dominant feature in
TCR-mediated T cell activation.
Taken together, these data explain survival and expansion of
the CD8
+CD28
2 population. But, we do not yet have an answer
to the question, why, almost exclusively the CD8
+CD28
2 and not
the CD8
+CD28
+ become activated by Sp1. Various scenarios are
possible and will need to be addressed in the future. 1. The lack of
expression of the CD28 co-stimulatory surface molecule might
promote better binding of Sp1 to the TCR due to less steric
hindrance. 2. The lack of expression of the CD28 molecule on the
T cell surface is associated with a phenotype and functionally
unique cell biology. Consequently, other molecules that remain to
be identified may be as relevant as the CD28 protein for the
susceptibility of CD8
+CD28
2 T cell activation by Sp1. 3. Post-
translational modifications such as glycosylation of proteins play a
key role in immune regulation [77,78]. Changes of the
glycosylation state, mainly desialysation have been shown to
enhance class I MHC-TCR interactions and T cell stimulation
[78]. ZPSs are repetitive highly charged molecules. It seems
conceivable that binding of ZPS enhances cross-linking of TCRs
due to different charge states of the TCR or co-receptors on
CD28
2 and CD28
+ T cells. The enhanced cross-linking of TCR
caused by a polysaccharide antigen represents an exciting novel
mechanism in cellular immunology. Further investigations will be
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of CD8
+ effector and regulatory T cells.
In conclusion, ZPS from commensal bacteria represent a
unique class of antigens that exhibit multiple functions on different
host cells and contribute to the maintenance of peripheral
tolerance. Here we demonstrate that the ZPS Sp1 induces
regulatory CD8
+ T cells inhibiting CD4
+ T cell immune responses
in vitro and in vivo. The Sp1-induced CD8
+CD28
2 Ts increase the
knowledge of physiologic bacterial antigens and with it, the
possibility to develop cell-based therapies against unwanted
immune responses in human beings.
Materials and Methods
Ethics statement
Animal experiments were performed in accordance with the
German animal protection legislation guidelines (article K07/05
and K16.5/06) and approved by the ‘‘Bezirksregierung Ko ¨ln’’,
Germany.
Antigens
S. pneumoniae type 1 capsular polysaccharide complex was
obtained from the American Type Culture Collection and further
purified to obtain homogeneity as previously described [10].
Chemical modification of Sp1 by neutralization of the free amino
group on the 2-acetamido-4-amino-2,4,6-trideoxygalactose by N-
acetylation that creates a polysaccharide with a net negative
charge was performed as previously described [1]. The capsular
polysaccharide of group B streptococcus serotype III (GBSIII) was
kindly provided by Dennis L. Kasper. High-resolution (500 MHz)
proton NMR spectroscopy [7] revealed that Sp1 and modified Sp1
(mSp1) were free of contaminating protein and nucleic acids.
Endotoxin was not detectable by the limulus test with a sensitivity
of ,8 pg LPS/mg Sp1. The peptides ASN (sequence H-
ASNENMETM-OH) and GP
33–41 (sequence H-KAVYNSATM-
OH) were obtained from Mimotopes, the SIINFEKL (sequence
H-SIINFEKL-OH) from JPT.
Mice
Wildtype C57BL/6 mice were obtained from Charles River
Laboratories. OT-1 C57BL/6 mice expressing a transgenic
receptor specific for the ovalbumin peptide sequence SIINFEKL
were obtained from Jackson Laboratories. P14 TCR-tg C57BL/6
(P14) mice expressing a transgenic receptor for the GP
33–41
peptide sequence of the lymphocytic choriomeningitis virus were
generously provided by J. P. Schneck [79]. Mice were kept in
special pathogen-free environments.
Experimental model of abscess formation
In the abscess induction studies, 6–8 week-old mice were
injected intraperitoneally with Sp1 or modified Sp1 (mSp1)
(100 mg in PBS mixed with sterile cecal content (SCC) adjuvant;
1:1 v/v, 0.2 ml total volume) or SCCA alone, as control [10]. SCC
is a required steril adjuvant in this model and mimics leakage of
the intestinal flora during secondary peritonitis [1]. For the
preparation of SCC, cecal content of non-treated mice is grinded
through 100 mm-pore size meshes and autoclaved thereafter. The
SCC dose not able to induce abscesses when applied alone is
determined by titration in the experimental model of abscess
formation. In order to block CD4
+ or CD8
+ T cells intraperito-
neally, 24 h prior to challenge, mice were injected intravenously
with a CD4-specific mAb (clone YTS 169, 500 mg per mouse) or a
CD8-specific mAb (clone YTS 191, 500 mg per mouse), or left
untreated. Depletion of CD4
+ T cells and CD8
+ T cells was
confirmed by flow cytometry analysis of whole blood and spleen
cells 24 h and 48 h after injection. Analysis showed depletion of
.95% of the CD4
+ and CD8
+ T cell population (data not shown).
For adoptive transfer studies, CD8
+CD28
2 or CD8
+CD28
+ T
cells (4610
5 per mouse) were injected intraperitoneally at the time
of polysaccharide challenge. Six days after challenge, mice were
macroscopically examined for the presence of abscesses within the
peritoneal cavity by two double-blinded examiners. Abscesses were
isolated and their diameter measured. In each experiment, four to
six mice per group were tested. The experiments were performed
three times in an independent manner.
Immunohistochemistry
Snap-frozen abscesses were cryo-sectioned (5–6 mm), fixed in
4% buffered formalin for 1 min and then used for immunohis-
tochemical analysis of CD8
+ T cells. After blocking endogenous
peroxidase by 0.3% H2O2 in methanol, and endogenous biotin
with an avidin-biotin blocking kit (Vector Laboratories) for
30 min, sections were treated with normal goat serum then
incubated overnight with an anti-CD8 antibody (1:50; rat anti-
mouse CD8, clone Ly-2, BD). Next, goat biotin-conjugated anti-
rat antibodies (1:100, BD) were applied and incubated for 1 h at
room temperature followed by incubation with alkaline phospha-
tase-conjugated streptavidin-Ab complex (Dako) for 30 min.
Immunostaining was achieved using Fast Red (Dako) as a
substrate for alkaline phosphatase. Sections were then counter-
stained with hemalaun.
Cells and cell culture
Peritoneal cells were obtained at different times following
intraperitoneal Sp1, mSp1, or PBS challenges. Mice underwent
peritoneal lavage with 4 ml of ice-cold RPMI-1640 supplemented
with 10% FBS and 1% penicillin/streptomycin. Total cell count
was obtained with a hemocytometer after trypan blue staining.
Each sample was then analyzed by flow cytometry.
CD4
+ and CD8
+ T cells were enriched from spleens of C57BL/6
mice by, grinding the tissue through a 70 mm mesh, lysis of red
blood cells,centrifuginginFicoll-Hypaquegradients (density1,083),
and, immunomagnetic negative selection according to the manu-
facturer’s instructions (Miltenyi Biotec, R&D). The purity of the cell
population was confirmed by flow cytometry (.95%).
CD8
+CD28
2 and CD8
+CD28
+ T cells were isolated as follows.
CD8
+ T cells were incubated with PE-labeled anti-CD28 mAb for
20 min, washed, centrifuged, and incubated with anti-PE-
microbeads for 15 min at 4uC (Miltenyi). Alternatively, CD8
+ T
cells were incubated with a biotinylated anti-CD28 mAb for
10 min at 4uC, washed, centrifuged, and labeled with streptavidin-
APC for 15 min at 4uC. PE- or APC-labeled CD28
+ cells were
enriched by positive selection using anti-PE- or anti-APC-labeled
microbeads, respectively (Miltenyi). Magnetic negative selection of
CD28
2 was performed following the manufacturer’s instructions
(Miltenyi). For adoptive transfer studies of CD28
2 and CD28
+ T
cells, CD8
+ T lymphocytes were stained with FITC-labeled anti-
CD8 and PE-labeled anti-CD28 for 20 min on ice. CD8
+CD28
2
and CD8
+CD28
+ T lymphocytes were sorted electronically using a
FACSVantage (BD) More than 93% purity was routinely obtained
(Fig. S1).
DCs were generated from mouse bone marrow by adapting a
previously described method [80]. In brief, bone marrow cells from
C57BL/6 or Balb/c mice were cultured in RPMI-1640 supple-
mented with 5% FBS, 500 U recombinant mouse granulocyte/
macrophage-colony stimulating factor (GM-CSF), 20 mg/ml gen-
tamicin, and 50 mM 2-mercaptoethanol. The DC medium was
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sorting with a CD11c-specific mAb (Miltenyi Biotec).
Experiments involving overnight culturing of WT CD8
+ T cells
were performed in RPMI-1640 supplemented with 1% L-
glutamine, sodium pyruvate, penicillin-streptomycin, non-essential
amino-acids, 50 mM 2-ME, 10% FBS (Life Technologies), and
purified anti-CD3 mAb (5 ng/ml). Cell culture with abrogated
contact between WT APCs and T cells were performed with the
CD8
+ T cells in the upper chamber of transwell inserts with a
0.4 mm pore size (Corning) and spleen cells in the lower chamber.
In experiments with OT-1 CD8
+ T cells, instead of purified anti-
CD3 mAb, SIINFEKL was used at a concentration of 10
29 M.
Co-cultering of purified CD8
+ T cells from OT-1 mice with
SIINFEKL-loaded H2K
b dimers was performed as followed:
MHC class I-Ig dimer (Kb-Ig; BD) were loaded with peptide by
incubation in a 40-fold molar excess of the specific peptide
SIINFEKL as instructed by the manufacturer. 5610
5 purified
CD8
+ T cells from OT-1 mice were incubated with SIINFEKL-
loaded MHC class I-Ig dimers (8 mg) in the absence or presence of
Sp1 (100 mg/ml) in 200 ml culture medium at 37uC overnight
Flow cytometry and intracellular cytokine staining
For staining surface markers, cells were stained with specific
antibodies for 30 min on ice, washed, and then analyzed by flow
cytometry.
To analyze the cellular intraperitoneal influx, the absolute
number of each respective cell type present in the peritoneal
lavage was calculated by taking the proportion of each cell type as
determined by flow cytometry and multiplying it by the total
number of cells per ml of lavage obtained from each mouse.
For intracellular cytokine staining (ICS), cells were stimulated
with anti-CD3 (5 ng/ml) for 6 h at 37uC and 5% CO2. After the
first hour of incubation, Golgi Stop (BD) was added. Cells were
stained for surface markers by 30 min on ice with specific
antibodies, washed, fixed with Cytofix/Cytoperm (BD) for 20 min
on ice, then permeabilized with Perm/Wash Solution (BD) for
10 min on ice and treated with interleukin-specific antibodies for
30 min at 4uC in Perm/Wash Solution.
The apoptotic capability of Sp1-treated CD8
+ T cells was
analyzed after staurosporine treatment using Annexin V staining.
1610
6 CD8
+ T cells/ml isolated from the spleens of C57BL/6
mice were incubated in medium (RPMI-1640 supplemented with
5% FCS) containing 1 mM staurosporine (Streptomyces sp., Calbio-
chem-Novabiochem) in the presence of Sp1, mSp1 (100 mg/ml,
respectively), or in medium alone. Cells were washed after 4 h to
free cells from staurosporine. Thereafter, cells were incubated in
fresh medium plus antigens for another 8 h. As a control, medium
without staurosporine was used. After washing, cells were dissolved
in binding buffer (0.1 M Hepes/NaOH (pH 7.4), 1.4 M NaCl,
25 mM CaCl (BD)) and stained with FITC-conjugated Annexin V
(5 ml/1610
6 cells; BD Apoptosis Detection Kit) for 15 min on ice.
Cells were washed, and 5 ml propidium iodide (PI) (BD) was added
to the cells for 2 min. The PI staining was stopped by the addition
of 5 ml of ice-cold PBS. Cells were washed and prepared for flow
cytometry.
Purified, FITC-, PE-, or APC-labeled monoclonal antibodies
specific to murine CD8 (clone RM4-5, BD), CD25 (clone 7D4,
BD), CD28 (clone 37.51, BD), CD44 (clone IM7, BD), CD62L
(clone MEL-14, BD), CD69 (clone H1.2F3, BD), CD39 (clone
TU66, BD), CD122 (clone TM-BETA 1, Serotec), LAP (clone
27232, R&D), CTLA-4 (clone UC10-4B9, eBioscience), and the
respective isotype controls were used for surface marker staining.
For ICS, mIL-6 (clone MP5-20F3, BD), anti-mouse mIL-10 (clone
JES5-16E3, BD), and the respective isotype controls were used.
Cells prepared for flow cytometry were analyzed – after gating for
viable cells by forward and side scatter - with FACS Calibur
TM
(Becton Dickinson) using CELLQuest
TM software (Becton Dick-
inson). The results were expressed as percentage (%) or mean
fluorescence intensity (MFI) of fluorescence-labeled cells in a
population. Experiments were performed a minimum of three
times in an independent manner.
Mixed leukocyte reaction
Allogeneic mixed leukocyte reaction (MLR) was performed as
described previously [81]. DCs from Balb/c mice (H-2d
haplotype) were incubated with negatively selected (Miltenyi)
and CFSE-labeled CD4
+ T cells of C57BL/6 mice (H-2b
haplotype) (1.5610
5/well) in the absence or presence of
CD8
+CD28
2 or CD8
+CD28
+ T cells isolated from C57BL/6
mice (5610
5/well) treated for 18 h with Sp1 (100 mg/ml). Cells
were incubated for 5 days at 37uC, 5% CO2. Proliferation of
CFSE-labeled CD4
+ T cells was evaluated by flow cytometry.
Western blotting
For the analyses of Zap-70 and caspase 3 activity, magnetically
separated CD8
+, CD8
+CD28
2 and CD8
+CD28
+ were incubated
in medium (RPMI-1640 supplemented with 5% FCS) in the
presence of Sp1, mSp1 (100 mg/ml, respectively), or in medium
alone for 4 h at 37uC. For analysis of caspase 3 activity, cells were
treated in medium containing 1 mM staurosporine. Whole cell
extracts were denatured at 100uC for 10 minutes. Equal amounts
of protein were separated by 14% Tris-glycine sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Western
blotting was performed with purified mouse anti-Phospho-Zap-70
(Tyr319)/Syk (Tyr352) (Cell Signaling Technology), mouse anti-
Zap-70 kinase (clone 29/ZAP70 kinase, BD), rabbit anti-caspase 3
(clone 8G10, Cell Signaling Technology), anti-ß-actin (clone AC-
15, Sigma Aldrich), goat anti-mouse IgG HRP, and goat anti-
rabbit IgG HRP (R&D) antibodies as described previously [48].
NF-kB Analysis
Magnetically separated CD8
+, CD8
+28
2 and CD8
+CD28
+ T
cells were treated with Sp1, mSp1 (100 mg/ml, respectively) or left
untreated for 2 h at 37uC in medium (RPMI-1640 supplemented
with 5% FCS) for 2 h. Cells were washed, counted, and incubated
for 15 min in low salt buffer on ice before NP-40 was added. After
sedimenting the nuclei, a high salt buffer was added slowly. The
nuclear extract is separated from the nuclear envelop/DNA by
centrifuging at maximum speed. A BCA assay was performed to
determine the protein concentration. The NF-kB ELISA was
performed according to the manufacturer’s instructions (Active
Motif). As positive control the nuclear extract from Jurkat cells was
used.
Dimer and binding assays
MHC class I-Ig Dimer (Db-Ig) were prepared as described
previously [50,82]. Db-Ig dimers were labeled with fluorescein
isothiocyanate (FITC; Molecular Probes) at pH 7.4 and purified
by gel column chromatography. Concentration of protein and dye
was measured by assessing the absorbance at 280 nm and 496 nm
respectively. For loading, FITC-labeled Db-Ig dimers were
incubated in a 50-fold molar excess of the specific peptide GP
33–41
and a two fold-molar excess of human b2-microglobulin for five days
at 4uC. ASN was used as a control peptide to address nonspecific
binding. For binding assays, CD8
+ T cells were isolated from P14
mice. 1610
5 cells were incubated with varying amounts of protein-
loaded Db-Ig dimers in the presence or absence of Sp1 (100 mg/ml)
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was measured by flow cytometry. Subtraction of the nonspecific
binding (
ASNDb-Ig) from the total binding (
GP33–41Db-Ig) determined
the specific binding. The single site equilibrium dissociation constant
(Kd), the equilibrium cross-linking constant (Kx) and the total number
of receptors available for binding (Rt)w e r ec a l c u l a t e du s i n gM i c r o c a l
Origin 6.1 software (Origin Lab Corporation, Northampton,
USA) [50].
Statistical analysis
Results of peritoneal cytokine and cellular influx assays in the
various groups were compared by Student’s t-test. Comparison of
groups with regard to abscess formation was made by chi-square
analysis. Results of NF-kB ELISA were compared by Student’s
t-test.
Supporting Information
Figure S1 Purity of CD8
+CD28
2 and CD8
+CD28
2 T cells.
CD28
2 and CD28
+ CD8
+ cells for adoptive transfer studies were
sorted by flow cytometry as described in the Materials and
Methods section and evaluated for their purity.
Found at: doi:10.1371/journal.ppat.1000596.s001 (0.02 MB PDF)
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